Compared to the treatment group comprising patients over 90 years old, those who were aged under 90 years exhibited no significant differences in sex ratio, cause of liver disease, proportion of patients with cirrhosis, mean CP score, and MELD score for cirrhosis, clinical stage of HCC, BCLC stage, AFP value, tumor maximum diameter, tumor number, and treatment methods. This evidence concerns the gene AFP and hepatocellular carcinoma.